United States Biotechnology & Medical Research

Entia Biosciences Inc (ERGO)

Track

Ticker: ERGO Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ANDRES DEVIN D. COO, VP, Sales and Marketing Officer
Transaction date
Purchase
Price
423.79
Quantity 25,890 +47.1%
Value US$4,654,504
HAUSMAN MARVIN S MD President, CEO, Acting CFO Executive Director Large shareholder
Transaction date
Purchase
Price
150.32
Quantity 65,651 -11.2%
Value US$3,633,026
HAUSMAN MARVIN S MD President, CEO, Acting CFO Executive Director Large shareholder
Transaction date
Purchase
Price
186.62
Quantity 1,325 +36.4%
Value US$3,631,968
ANDRES DEVIN D. COO, VP, Sales and Marketing Officer
Transaction date
Purchase
Price
0.38
Quantity 52,089 +35.0%
Value US$19,794
HAUSMAN MARVIN S MD President, CEO, Acting CFO Executive Director Large shareholder
Transaction date
Purchase
Price
0.38
Quantity 131,579 +5.7%
Value US$50,000
ANDRES DEVIN D. COO, VP, Sales and Marketing Officer Large shareholder
Transaction date
Purchase
Price
0.38
Quantity 131,579 +757.8%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-11-12 2014-09-25 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer
25,890 +47.1%
423.79
US$4,654,504 		25,890 +47.1% 423.79 US$4,654,504
2014-11-12 2014-09-25 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
65,651 -11.2%
150.32
US$3,633,026 		65,651 -11.2% 150.32 US$3,633,026
2013-12-19 2013-12-17 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
1,325 +36.4%
186.62
US$3,631,968 		1,325 +36.4% 186.62 US$3,631,968
2013-12-19 2013-12-17 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer
52,089 +35.0%
0.38
US$19,794 		52,089 +35.0% 0.38 US$19,794
2013-07-22 2013-07-12 B Purchase HAUSMAN MARVIN S MD

President, CEO, Acting CFO

Executive Director Large shareholder
131,579 +5.7%
0.38
US$50,000 		131,579 +5.7% 0.38 US$50,000
2013-06-12 2013-06-11 B Purchase ANDRES DEVIN D.

COO, VP, Sales and Marketing

Officer Large shareholder
131,579 +757.8%
0.38
US$50,000 		131,579 +757.8% 0.38 US$50,000
Explore more

More insider trading research around Entia Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America